Abstract:Background: Bicuspid aortic valve (BAV) disease is the most common congenital cardiac abnormality affecting 1-2% of the population and is associated with a significantly increased risk of ascending aortic aneurysm. However, predicting which patients will develop aneurysms remains a challenge. This pilot study aimed to identify candidate plasma biomarkers for monitoring ascending aortic diameter and predicting risk of future aneurysm in BAV patients. Methods: Plasma samples were collected pre-operatively from BAV patients undergoing aortic valve surgery. Maximum ascending aortic diameter was measured on pre-operative transoesophageal echocardiography. Maximum diameter ≥ 45 mm was classified as aneurysmal. Sequential Window Acquisition of all THeoretical Mass Spectra (SWATH-MS), an advanced mass spectrometry technique, was used to identify and quantify all proteins within the samples. Protein abundance and aortic diameter were correlated using logistic regression. Levene's test was used to identify proteins demonstrating low abundance variability in the aneurysmal patients (consistent expression in disease), and high variability in the non-aneurysmal patients (differential expression between 'at risk' and not 'at risk' patients). Results: Fifteen plasma samples were collected (seven non-aneurysmal and 8 aneurysmal BAV patients). The mean age of the patients was 55.5 years and the majority were female (10/15, 67%). Four proteins (haemoglobin subunits alpha, beta and delta and mannan-binding lectin serine protease) correlated significantly with maximal ascending aortic diameter (p < 0.05, r = 0.5-0.6). Five plasma proteins demonstrated significantly lower variability in the aneurysmal group and may indicate increased risk of aneurysm in non-aneurysmal patients (DNA-dependent protein kinase catalytic subunit, lumican, tetranectin, gelsolin and cartilage acidic protein 1). A further 7 proteins were identified only in the aneurysmal group (matrin-3, glucose-6-phosphate isomerase, coactosin-like protein, peptidyl-prolyl cis-trans isomerase A, golgin subfamily B member 1, myeloperoxidase and 2'-deoxynucleoside 5'-phosphate N-hydrolase 1). Conclusions: This study is the first to identify candidate plasma biomarkers for predicting aortic diameter and risk of future aneurysm in BAV patients. It provides valuable pilot data and proof of principle that could be used to design a large-scale prospective investigation. Ultimately, a more affordable 'off-the-shelf' follow-on blood assay could then be developed in place of SWATH-MS, for use in the healthcare setting.

miR-130a expression is related to aortic dilation in bicuspid aortic valve children

Integrative Analysis of Key Microrna-Mrna Complexes and Pathways in Aortic Aneurysm

Medial tunica degeneration of the ascending aortic wall is associated with specific microRNA changes in bicuspid aortic valve disease

MicroRNAs Involve in Bicuspid Aortic Aneurysm: Pathogenesis and Biomarkers

MicroRNA Profiling of Plasma Extracellular Vesicles in Bicuspid Aortopathy

Hemodynamic predictors of aortic dilatation in bicuspid aortic valve by velocity-encoded cardiovascular magnetic resonance

Aorta Measurements are Heritable and Influenced by Bicuspid Aortic Valve.

Plasma proteomic profiling reveals biomarkers associated with aortic dilation in patients with bicuspid aortic valve

Two MicroRNAs, Mir-34A and Mir-125A, Are Implicated in Bicuspid Aortopathy by Modulating Metalloproteinase 2

Connecting the dots: molecular pathways in bicuspid aortopathy explored

miRNA-Driven Regulation of Endothelial-to-Mesenchymal Transition Differs among Thoracic Aortic Aneurysms

Recurrent Germline Mutations As Genetic Markers for Aortic Root Dilatation in Bicuspid Aortic Valve Patients

Multimodality imaging in bicuspid aortic valve

Circulating Soluble Receptor of Advanced Glycation End Product is Associated with Bicuspid Aortic Aneurysm Progression Via NF-κB Pathway.

Plasma Exosomal Mir-423-5p is Involved in the Occurrence and Development of Bicuspid Aortopathy Via TGF-β/SMAD2 Pathway

Effect of beta-blockers and angiotensin receptor blockers in reducing the aortic growth rate in children with bicuspid aortic valve-related aortopathy

Aortic Dilatation in Patients With Bicuspid Aortic Valve

Circulating Matrix Metalloproteinase Patterns in Association with Aortic Dilatation in Bicuspid Aortic Valve Patients with Isolated Severe Aortic Stenosis

Prognostic Role of Aortic Distensibility in Patients with Bicuspid Aortic Valve: a CMR Study

[Expression of Mir-146B in Peripheral Blood Serum and Aortic Tissues in Patients with Acute Type Stanford A Aortic Dissection and Its Clinical Significance].

Candidate plasma biomarkers for predicting ascending aortic aneurysm in bicuspid aortic valve disease